KAZOCEF-DX-LB
Description_Effects
KAZOCEF-DX-LB / Sanicif-DX-LB Tablet is a powerful combination antibiotic formulation containing Cefixime 200mg, Dicloxacillin 500mg, and LAB 90MS (Lactic Acid Bacillus 90 million spores). It is used to treat a variety of bacterial infections, including those of the respiratory tract, urinary tract, skin, soft tissues, and ENT (ear, nose, throat) infections. Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting the synthesis of bacterial cell walls, ultimately killing the bacteria. Dicloxacillin, a penicillin-class antibiotic, is effective against gram-positive bacteria, including penicillin-resistant Staphylococcus species, making this combination suitable for treating mixed or resistant infections. LAB 90MS, or Lactic Acid Bacillus, is a probiotic added to the formulation to help restore the balance of beneficial bacteria in the gut that may be disrupted by antibiotic use. It helps in preventing antibiotic-associated diarrhea and promotes digestive health during treatment. This triple-action formula offers broad-spectrum antibacterial coverage while protecting gastrointestinal health, ensuring better tolerance and treatment outcomes. KAZOCEF-DX-LB / Sanicif-DX-LB is typically well-tolerated when taken as prescribed. For best results and safety, it should be used under medical supervision and as directed by a healthcare provider.
